Bleach vs. Bubbles: Assessing the Impact of the Bathroom Environment on Eczema

Sponsor
University of North Carolina, Chapel Hill (Other)
Overall Status
Completed
CT.gov ID
NCT03619161
Collaborator
(none)
58
1
3
17.9
3.2

Study Details

Study Description

Brief Summary

Purpose: Evaluate the impact of cleaning the bathroom environment on the severity of eczema. Determine if part of the efficacy of bleach baths may be in cleaning the bathroom. Record data on the process in order to improve future interventions.

Participants: Patients and families with eczema

Procedures (methods):
  • Obtain baseline eczema severity scores and bacterial cultures from bathtubs

  • Randomize subjects to receive (1) a bathtub culture alone; (2) a culture and bathroom cleaning; and (3) a culture, cleaning, and bleach baths.

  • Measure changes in eczema severity scores over 4 weeks

  • Qualitatively evaluate the process by participants and investigators

Condition or Disease Intervention/Treatment Phase
  • Other: Bubbles
  • Other: Bleach and Bubbles
N/A

Detailed Description

The study will evaluate the effect of two interventions.

  1. At the start of the study, two-thirds of the patients (40 patients) will be randomized to have a culture taken from their bathtub with subsequent cleaning of all of their bathrooms (intervention arm) versus one-third (20 patients) only obtaining a culture taken from their bathtub with no cleaning (control arm).

  2. After cleansing the bathrooms in the intervention arm, this group will be randomized again so that half of this group (20 patients) receives instructions on performing twice weekly bleach baths and the other half (20 patients) does not.

  3. When the intervention period ends at 4 weeks, the placebo arm will be offered a bathroom cleaning.

There will be four quantitative assessment phases:
  1. Upon entry into the study the investigators will obtain basic demographic information (insurer, age, race/ethnicity), a history of skin infections and allergic diseases, an eczema severity score (POEM score), an eczema area and severity index score (EASI score), and record the participant's level of eczema therapy (weak-moderate topical steroids, strong topical steroids, or systemic immunomodulators).

  2. The investigators will obtain a culture from the bathtub used by every study subject. This will be prior to cleaning the bathroom if the participant is in the cleaning intervention arm.

  3. The investigators will obtain a POEM score over the phone 1 week after obtaining the cultures.

  4. After 4 weeks, the investigators will obtain a POEM score over the phone as well as document whether the participant received any antibiotics or had any visits to medical providers for atopy flares over the last 4 weeks. The investigators will also re-record the participant's level of eczema therapy (weak-moderate topical steroids, strong topical steroids, or systemic immunomodulators).

There will be one qualitative assessment:

Additionally, the study team will keep field notes documenting perceptions and experiences during the cleaning process. These qualitative documents will be used for process evaluation to improve home hygiene interventions and studies. Domains that the investigators will assess in field notes include:

  1. Environment: The general appearance of the exterior of the home and neighborhood, cleanliness and order within the home and bathrooms, the hospitality and dynamics of interacting with the family. The investigators will also take pictures of the bathroom before and after each cleansing.

  2. Work difficulty: Description of activities performed and any physical, mental, and emotional toil related to the labor with suggestions for improving the work experience.

  3. Assessment of usefulness to the family: Did the family find the intervention useful? Did the family mention ways to make the cleaning intervention better? If given bleach bath instructions, did the family appear receptive and willing to do bleach baths? Did it appear that the family would clean their bathroom regularly after the intervention?

Study Design

Study Type:
Interventional
Actual Enrollment :
58 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Bleach vs. Bubbles: Assessing the Impact of the Bathroom Environment on Eczema
Actual Study Start Date :
Jun 21, 2018
Actual Primary Completion Date :
Dec 18, 2019
Actual Study Completion Date :
Dec 18, 2019

Arms and Interventions

Arm Intervention/Treatment
No Intervention: No cleaning (control)

Patients will have a bacterial culture taken from their bathtub and then continue regular care. We will offer to clean their bathrooms after the 4 week intervention period ends.

Experimental: Bubbles

Patients will have a bacterial culture taken from their bathtub and have their bathrooms cleaned by the investigators

Other: Bubbles
All bathrooms with showers or bathtubs will be cleansed with simple products (dilute bleach, dilute white vinegar, baking soda, and dilute Dawn dish soap)
Other Names:
  • cleaning
  • Active Comparator: Bleach and Bubbles

    Patients will have a bacterial culture taken from their bathtub, have their bathrooms cleaned by the investigators, and be given instructions to perform bleach baths twice weekly.

    Other: Bleach and Bubbles
    All bathrooms with showers or bathtubs will be cleansed with simple products (dilute bleach, dilute white vinegar, baking soda, and dilute Dawn dish soap).
    Other Names:
  • cleaning
  • bleach bath
  • Outcome Measures

    Primary Outcome Measures

    1. Absolute change in POEM score From Baseline (day 0) to Week 4 (day 28) [Baseline (day 0) to Week 4 (day 28)]

      POEM is a 7-item questionnaire that assesses disease symptoms (dryness, itching, flaking, cracking, sleep loss, bleeding, and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease). A higher POEM score correlates with a poorer quality of life (QOL).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    6 Months to 17 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Children with eczema who visit UNC pediatric dermatology during study enrollment (Summer 2018).

    • Currently on a class 1 topical steroid or systemic immunosuppressive agent to control his/her eczema at the time of recruitment.

    • A history of, or current clinical evaluation by the attending dermatologist showing, atopic dermatitis affecting at least 10% body surface area.

    Exclusion Criteria:
    • Child or family member with a sensitivity to bleach.

    • Child has used bleach baths within the last 2 months.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The University of North Carolina at Chapel Hill Chapel Hill North Carolina United States 27516

    Sponsors and Collaborators

    • University of North Carolina, Chapel Hill

    Investigators

    • Principal Investigator: Craig N Burkhart, MD, University of North Carolina, Chapel Hill

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of North Carolina, Chapel Hill
    ClinicalTrials.gov Identifier:
    NCT03619161
    Other Study ID Numbers:
    • 18-1227
    First Posted:
    Aug 7, 2018
    Last Update Posted:
    May 11, 2021
    Last Verified:
    May 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University of North Carolina, Chapel Hill
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 11, 2021